0001214659-20-003604.txt : 20200421
0001214659-20-003604.hdr.sgml : 20200421
20200421172625
ACCESSION NUMBER: 0001214659-20-003604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200420
FILED AS OF DATE: 20200421
DATE AS OF CHANGE: 20200421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Craig A
CENTRAL INDEX KEY: 0001370348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 20806036
MAIL ADDRESS:
STREET 1: C/O PURE BIOSCIENCE
STREET 2: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-48601.xml
PRIMARY DOCUMENT
X0306
4
2020-04-20
0001576263
Mirati Therapeutics, Inc.
MRTX
0001370348
Johnson Craig A
C/O MIRATI THERAPEUTICS INC.
9393 TOWNE CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
true
false
false
false
Common Stock
2020-04-20
4
M
false
15000
25.84
A
17000
D
Common Stock
2020-04-20
4
S
false
15000
93.00
D
2000
D
Non-Qualified Stock Option (Right to Buy)
25.84
2020-04-20
4
M
false
15000
0
D
2025-05-20
Common Stock
15000
0
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 10, 2020.
The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.
/s/ Vickie Reed, Attorney-in-Fact
2020-04-21